Hildebrandt Named Division Chief of Markey Hematology

LEXINGTON, Ky. (May 22, 2015) -- Dr. Gerhard Hildebrandt has been named the Division Chief of Hematology and Blood and Marrow Transplantation at the University of Kentucky Markey Cancer Center.

Hildebrandt's clinical focus is cancers of the blood and lymph system. He sees patients before and after blood or marrow stem cell transplantation and treats patients suffering from acute and chronic graft-versus-host disease. He also serves as a professor of medicine in the UK College of Medicine.

Hildebrandt received his medical degree from the Johannes Gutenberg University of Mainz Medical School, Germany, in 1997. Upon completing his doctoral research thesis, he was awarded the "doctor medicinae" with magna cum laude.

He then completed a residency in Internal Medicine and a Hematology and Oncology fellowship at the University of Regensburg, Germany and became Bone Marrow Transplant and Hematologic Malignancies Attending at the University of Regensburg. In 2009 he was awarded the "Habilitation," the highest academic qualification a scholar can achieve by own pursuit in Germany.

After moving to the United States in 2009, Hildebrandt was a faculty member at Louisiana State University in Shreveport and served as director of their bone marrow transplant program. He later moved to the University of Utah in Salt Lake City to become director of the Utah Blood and Marrow Transplant program at the Huntsman Cancer Institute.

Hildebrandt is a member of the American Society of Hematology, the American Society of Clinical Oncology, the American Society for Blood and Marrow Transplantation and the American Association for Cancer Research. He has authored more than 40 articles, books and book chapters, and is strongly involved in clinical trials.